241 related articles for article (PubMed ID: 18805483)
1. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion.
Krause J; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2009 Jan; 71(1):138-44. PubMed ID: 18805483
[TBL] [Abstract][Full Text] [Related]
2. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
[TBL] [Abstract][Full Text] [Related]
3. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
[TBL] [Abstract][Full Text] [Related]
4. Production of pellets via extrusion-spheronisation without the incorporation of microcrystalline cellulose: a critical review.
Dukić-Ott A; Thommes M; Remon JP; Kleinebudde P; Vervaet C
Eur J Pharm Biopharm; 2009 Jan; 71(1):38-46. PubMed ID: 18771727
[TBL] [Abstract][Full Text] [Related]
5. Taste-masking properties of solid lipid based micropellets obtained by cold extrusion-spheronization.
Petrovick GF; Breitkreutz J; Pein-Hackelbusch M
Int J Pharm; 2016 Jun; 506(1-2):361-70. PubMed ID: 27132502
[TBL] [Abstract][Full Text] [Related]
6. Spheronization of solid lipid extrudates: A novel approach on controlling critical process parameters.
Petrovick GF; Pein M; Thommes M; Breitkreutz J
Eur J Pharm Biopharm; 2015 May; 92():15-21. PubMed ID: 25681745
[TBL] [Abstract][Full Text] [Related]
7. Preparation of lipid aspirin sustained-release pellets by solvent-free extrusion/spheronization and an investigation of their stability.
Yan X; He H; Meng J; Zhang C; Hong M; Tang X
Drug Dev Ind Pharm; 2012 Oct; 38(10):1221-9. PubMed ID: 22713120
[TBL] [Abstract][Full Text] [Related]
8. Effect of drying on extruded pellets based on kappa-carrageenan.
Thommes M; Blaschek W; Kleinebudde P
Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
[TBL] [Abstract][Full Text] [Related]
9. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters.
Thommes M; Kleinebudde P
AAPS PharmSciTech; 2007 Nov; 8(4):E95. PubMed ID: 18181555
[TBL] [Abstract][Full Text] [Related]
10. Quantification of mass transfer during spheronisation.
Koester M; Thommes M
AAPS PharmSciTech; 2012 Jun; 13(2):493-7. PubMed ID: 22415640
[TBL] [Abstract][Full Text] [Related]
11. Influence of MCC II fraction and storage conditions on pellet properties.
Krueger C; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
13. Development of starch-based pellets via extrusion/spheronisation.
Dukić A; Mens R; Adriaensens P; Foreman P; Gelan J; Remon JP; Vervaet C
Eur J Pharm Biopharm; 2007 Apr; 66(1):83-94. PubMed ID: 17045467
[TBL] [Abstract][Full Text] [Related]
14. Preliminary assessment of carrageenan as excipient for extrusion/spheronisation.
Bornhöft M; Thommes M; Kleinebudde P
Eur J Pharm Biopharm; 2005 Jan; 59(1):127-31. PubMed ID: 15567309
[TBL] [Abstract][Full Text] [Related]
15. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties.
Verheyen P; Steffens KJ; Kleinebudde P
Drug Dev Ind Pharm; 2009 Nov; 35(11):1325-32. PubMed ID: 19832632
[TBL] [Abstract][Full Text] [Related]
16. Taste masked lipid pellets with enhanced release of hydrophobic active ingredient.
Vaassen J; Bartscher K; Breitkreutz J
Int J Pharm; 2012 Jun; 429(1-2):99-103. PubMed ID: 22465412
[TBL] [Abstract][Full Text] [Related]
17. Characterization of laminar extrudates manufactured at room temperature in the absence of solvents for the delivery of drugs.
Oliveira G; Wahl MA; Pinto JF
Int J Pharm; 2013 Sep; 454(1):90-8. PubMed ID: 23845856
[TBL] [Abstract][Full Text] [Related]
18. Non-aqueous formulations for ram and screen extrusion-spheronisation.
Zhang M; Rough SL; Ward R; Seiler C; Wilson DI
Int J Pharm; 2019 Apr; 560():394-405. PubMed ID: 30763682
[TBL] [Abstract][Full Text] [Related]
19. Extrusion-spheronisation of microcrystalline cellulose pastes using a non-aqueous liquid binder.
Mascia S; Seiler C; Fitzpatrick S; Wilson DI
Int J Pharm; 2010 Apr; 389(1-2):1-9. PubMed ID: 20123008
[TBL] [Abstract][Full Text] [Related]
20. Multiple batch manufacturing of theophylline pellets using the wet-extrusion/spheronization process with κ-carrageenan as pelletisation aid.
Krueger C; Thommes M
Pharm Dev Technol; 2013 Feb; 18(1):225-35. PubMed ID: 22780876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]